Fortrea Clinical Research Unit
Fortrea Clinical Research Unit
Daytona Beach, Florida, United States12 results ยท Page 1 of 1
Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| A Study of LY4560736 in Healthy Participants and Participants With Alzheimer's Disease (AD) | Alzheimer disease, Pathological Conditions, Anatomical, Pathological Conditions, Signs and Symptoms, Plaque, Amyloid, amyloidosis, brain disorder, central nervous system disorder, cognitive disorder, dementia, nervous system disorder, neurodegenerative disease, psychiatric disorder, tauopathy | Not yet recruiting | Phase 1 | 2026-10-08 | NCT07843459 | |
| A Study of LY4329090 in Participants With Obesity or Overweight Who Are Otherwise Healthy | Body Weight, Nutritional and Metabolic Diseases, Overweight, Pathological Conditions, Signs and Symptoms, Signs and Symptoms, nutritional disorder, obesity disorder, overnutrition | Recruiting | Phase 1 | 2026-10-08 | NCT07808073 | |
| A Study of Eloralintide (LY3841136) in Female Participants With Obesity or Overweight | Body Weight, Nutritional and Metabolic Diseases, Overweight, Pathological Conditions, Signs and Symptoms, Signs and Symptoms, nutritional disorder, obesity disorder, overnutrition | Recruiting | Phase 1 | 2026-10-08 | NCT07808060 | |
| A Master Protocol Studying Multiple Amyloid-Targeting Therapies in Healthy Participants and Participants With Alzheimer's Disease | Alzheimer disease, Pathological Conditions, Anatomical, Pathological Conditions, Signs and Symptoms, Plaque, Amyloid, amyloidosis, brain disorder, central nervous system disorder, cognitive disorder, dementia, nervous system disorder, neurodegenerative disease, psychiatric disorder, tauopathy | Recruiting | Phase 1 | 2026-10-08 | NCT07787169 | |
| A Study of LY4268989 (MORF 057) in Healthy Participants | Healthy | Active, not recruiting | Phase 1 | 2026-10-08 | NCT07707375 | |
| A Study of LY3537031 in Overweight, Obese, and Healthy Participants | Body Weight, Nutritional and Metabolic Diseases, Overweight, Pathological Conditions, Signs and Symptoms, Signs and Symptoms, nutritional disorder, obesity disorder, overnutrition | Active, not recruiting | Phase 1 | 2026-09-30 | NCT06606106 | |
| A Study of Eloralintide (LY3841136) in Healthy Participants | Healthy Volunteers | Active, not recruiting | Phase 1 | 2026-09-29 | NCT07701083 | |
| A Study Comparing Two Ways of Taking Olomorasib (LY3537982) in Healthy Participants | Healthy Volunteers | Recruiting | Phase 1 | 2026-09-22 | NCT07794592 | |
| A Study of LY4405094 in Healthy Participants and Participants With Alzheimer's Disease | Alzheimer disease, Pathological Conditions, Anatomical, Pathological Conditions, Signs and Symptoms, Plaque, Amyloid, amyloidosis, brain disorder, central nervous system disorder, cognitive disorder, dementia, nervous system disorder, neurodegenerative disease, psychiatric disorder, tauopathy | Not yet recruiting | Phase 1 | 2026-09-22 | NCT07787182 | |
| A Study of LY4213663 in Healthy Participants and Participants With Rheumatoid Arthritis | Skin and Connective Tissue Diseases, arthritic joint disease, arthropathy, autoimmune disease, connective tissue disorder, immune system disorder, musculoskeletal system disorder, rheumatic disorder, rheumatoid arthritis | Recruiting | Phase 1 | 2026-06-23 | NCT07258849 | |
| A Study of LY4302814 in Healthy Participants | Healthy | Recruiting | Phase 1 | 2026-06-16 | NCT07566338 | |
| A Study of Mirikizumab Solution (LY3074828) in Healthy Participants | Healthy | Recruiting | Phase 1 | 2026-05-14 | NCT07446101 |